effects and prognostic factors of PD-1 inhibitors on malignant melanoma

effects and prognostic factors of PD-1 inhibitors on malignant melanoma - effects and prognostic factors of PD-1 inhibitors on malignant melanoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023195

Enrollment

Registered

2016-07-16

Start date

2015-10-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant melanoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: malignant melanoma with nivolumab treatment

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
blood test	—

Countries

Japan

Contacts

Public ContactHisako Okuhira

Wakayama Medical University Depertment of Dermatology

okuhisa@wakayama-med.ac.jp073-441-0661

Outcome results